Recipient IL28B Variant as Predictor of New Onset Diabetes Mellitus in Liver Transplant Patients with Chronic Hepatitis C
(2022). Recipient IL28B Variant as Predictor of New Onset Diabetes Mellitus in Liver Transplant Patients with Chronic Hepatitis C. EKB Journal Management System, 2(2), -. doi: 10.21608/esdlj.2022.455804
. "Recipient IL28B Variant as Predictor of New Onset Diabetes Mellitus in Liver Transplant Patients with Chronic Hepatitis C". EKB Journal Management System, 2, 2, 2022, -. doi: 10.21608/esdlj.2022.455804
(2022). 'Recipient IL28B Variant as Predictor of New Onset Diabetes Mellitus in Liver Transplant Patients with Chronic Hepatitis C', EKB Journal Management System, 2(2), pp. -. doi: 10.21608/esdlj.2022.455804
Recipient IL28B Variant as Predictor of New Onset Diabetes Mellitus in Liver Transplant Patients with Chronic Hepatitis C. EKB Journal Management System, 2022; 2(2): -. doi: 10.21608/esdlj.2022.455804

Recipient IL28B Variant as Predictor of New Onset Diabetes Mellitus in Liver Transplant Patients with Chronic Hepatitis C

Egyptian Society of Diabetes and Lipidology Journal
Volume 2, Issue 2, October 2022    PDF (660.74 K)
Document Type: Abstracts
DOI: 10.21608/esdlj.2022.455804
Abstract
New-onset diabetes after liver transplantation (NODAT) is increasingly recognized as a complication that affects the quality of life. In addition to well-known risk factors for diabetes in such patients, little is known regarding the genetic predisposition for this condition.
Statistics
Article View: 38
PDF Download: 11